Skip to main content

Find Clinical Trials

Home
Conditions
Hamartoma

Clinical trial condition

Hamartoma

Explore clinical trials studying Hamartoma. Study availability and eligibility vary by location and protocol.

108 public trials 27 recruiting studies

Refine in advanced search Browse all conditions

Hamartoma trial results

Not Yet Recruiting

A Phase 2 Study of the Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epilepsy

NCT07680322

Conditions: Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +21 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations

NCT07218575

Conditions: Autism Spectrum Disorder, Autistic Disorder, Bannayan Riley Ruvalcaba Syndrome, +18 more
Locations: Stanford University Stanford, California, United States

Boston Children's Hospital Boston, Massachusetts, United States

Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Not Yet Recruiting

Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME)

NCT07287202

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniofacial Abnormalities, +19 more
Locations: Austin Hospital Heidelberg, Victoria, Australia

The Alfred Melbourne, Victoria, Australia

View Trial Details

Completed

Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex

NCT02687633

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +13 more
Locations: UCLA Semel Insitute Los Angeles, California, United States

View Trial Details

Completed

Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

NCT00040222

Conditions: Adnexal Diseases, BRCA1-associate Malignancies, BRCA2-associated Malignancies, +42 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Gait in Rare Diseases

NCT05161494

Conditions: Central Nervous System Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
Locations: University of Antwerp Antwerp, Belgium

View Trial Details

Completed

A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex

NCT05864846

Conditions: Behavior, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations: Children's Hospital Colorado Aurora, Colorado, United States

Yale University School of Medicine New Haven, Connecticut, United States

University of Florida Health - Department of Neurology Gainesville, Florida, United States

Nicklaus Children's Health, Miami Miami, Florida, United States

View all 19 locations

View Trial Details

Completed

Remote Assessment and Intervention for Behavior Problems in Kids With TSC

NCT06311474

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +13 more
Locations: University of California, Los Angeles Los Angeles, California, United States

View Trial Details

Completed

Precision Medicine for Neurocutaneous Syndromes in Western China

NCT07327164

Conditions: Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +38 more
Locations: West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Completed

Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy

NCT05626634

Conditions: Brain Diseases, CDKL5 deficiency disorder, Central Nervous System Diseases, +23 more
Locations: Arkansas Children's Hospital Little Rock, Arkansas, United States

Rancho Los Amigos National Rehabilitation Center (RLANRC) Downey, California, United States

University of California San Francisco San Francisco, California, United States

Northwest Florida Clinical Research Group Gulf Breeze, Florida, United States

View all 28 locations

View Trial Details